Shandong Chuangye Pharmaceutical Technology Co., Ltd. was established in April 2019 with a registered capital of 3 million. It specializes in R&D and technology development services of impurity reference substances, pharmaceutical intermediates and APIs. The company’s R&D team brings together a group of outstanding industry elites, with 12 full-time synthetic researchers, rich in pharmaceutical R&D experience, fully equipped with the technical strength to develop various chemical drugs, and has its own uniqueness in product development, pilot production and process optimization The advantages. At the same time, the company has established in-depth cooperation with Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences and Institute of Applied Chemistry, Guizhou University.

The company’s existing superior products: Tedizolamide phosphate and intermediates, Alogliptin benzoate and intermediates, Trixagliptin succinate and intermediates, Dominant pharmaceutical intermediates, etc. The products comply with the Pharmacopoeia Standard, sufficient inventory, to provide customers with the best quality products and the most reasonable prices.

Adhering to the spirit of customer first and pursuing excellence, we continue to expand the capabilities of the company in all aspects, provide customers at home and abroad with better products and services, meet the increasing needs of customers, and contribute to the fight against diseases.